Jubilant Pharmova Announcements
USFDA Communication Montreal, Canada
04 Nov, 2025 | 08:10pm • Source: BSE
Jubilant Pharmova Limited has informed the Exchange about General Updates - Grant of Stock Options / RSUs
31 Oct, 2025 | 01:56pm • Source: NSE
Jubilant Pharmova Limited has informed the Exchange regarding Outcome of Board Meeting held on October 31, 2025. - Grant of Stock Options / RSUs
31 Oct, 2025 | 01:55pm • Source: NSE
Press Release along with Earning presentation
31 Oct, 2025 | 01:11pm • Source: BSE
Approval of Grant of Stock Options/RSUs
31 Oct, 2025 | 01:07pm • Source: BSE
Un-audited Financial Results for the quarter and half year ended September 30, 2025
31 Oct, 2025 | 01:05pm • Source: BSE
Outcome of the Board Meeting held on October 31, 2025
31 Oct, 2025 | 01:01pm • Source: BSE
Letter to shareholders whose KYC is not updated
27 Oct, 2025 | 05:49pm • Source: BSE
Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 ,inter alia, to consider and...
14 Oct, 2025 | 07:10pm • Source: BSE
Jubilant Pharmova Limited has informed the Exchange about General Updates - Press Release pertaining to the launch of New High-Speed Isolator based Line, at its...
10 Oct, 2025 | 09:45am • Source: NSE
Intimation under Reg 30 - Launch of New High Speed Isolator base line at its Spokane Manufacturing Facility in US by Jubilant HollisterStier LLC
10 Oct, 2025 | 08:03am • Source: BSE
Submission of communication email sent to shareholders whose dividend(s) remains unpaid pursuant to "Saksham Niveshak - 100 Days Campaign"
08 Oct, 2025 | 08:20pm • Source: BSE
Compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
07 Oct, 2025 | 04:55pm • Source: BSE
Copy of Newspaper Publication
01 Oct, 2025 | 11:35pm • Source: BSE
Allotment of Optionally Convertible Redeemable Non-Cumulative Preference Shares(OCRPS) by Jubilant Biosys Limited, a wholly owned subsidiary Company
01 Oct, 2025 | 01:29pm • Source: BSE
Appointment of CFO of the Company
23 Sep, 2025 | 11:40am • Source: BSE
Outcome of Board Meeting held on September 23, 2025
23 Sep, 2025 | 11:38am • Source: BSE
Disclosure under Regulation 30 - Jubilant Pharmova announces Completion of Pharmacovigilance Inspection by the USFDA with No Obervations
20 Sep, 2025 | 08:35pm • Source: BSE
Reminder email sent to shareholders intimating about the 100 days campaign
12 Sep, 2025 | 08:02pm • Source: BSE